Owning Elbit Systems directly means any bump it hits lands full force in your portfolio. Simply Wall St flags that its Aerospace arm and Elbit Systems of America already showed low single digit revenue declines, and that if US defense budgets grow only slowly or shift away from avionics and precision guided munitions, those areas could drag on wider results. Holding Elbit inside a fund with many businesses dilutes those specific risks, and also tempers any strong upside from the stock.
Recent numbers give you something new to weigh. Elbit Systems has reported third quarter 2026 revenue of US$2.3b and an order book of US$33b, described as a record level and tied to artificial intelligence combat technologies and contracts across Europe and Asia Pacific. That changes the mix of future work for the business and helps explain why some investors look at EIS, ISRA and ITEQ as ways to own Elbit inside a broader portfolio.
| Fund | Elbit Systems weight | Rank in fund by weight | 5-year annualised return after fees | Fee | Assets |
|---|---|---|---|---|---|
| iShares MSCI Israel ETF (EIS) | 5.24% | #4 of 129 | 9.0% | 0.59% | US$815.85 million |
| VanEck Israel ETF (ISRA) | 4.13% | #5 of 83 | 5.3% | 0.59% | US$145.42 million |
| Amplify BlueStar Israel Technology ETF (ITEQ) | 7.25% | #2 of 61 | -3.9% | 0.75% | US$96.77 million |
Prefer to pick the companies yourself? Start with 38 high quality undervalued stocks.
iShares MSCI Israel ETF (EIS)
EIS leans heavily toward Israeli financials and healthcare, with diversified banks, pharmaceuticals and multi line insurers taking large slices of the portfolio. Elbit Systems is a meaningful piece of your exposure at 5.24%, so roughly US$52 of every US$1,000 sits in that stock. Around it, you get very different businesses such as Teva Pharmaceutical Industries and Bank Leumi le-Israel B.M, which together already make up more than one fifth of the fund.
One risk for Elbit Systems is that defense spending stays in low single digit growth or moves away from avionics and precision guided munitions, which could pressure revenue and margins. EIS owns sectors that depend on consumer health demand or Israeli credit markets instead, so those holdings can offset shocks tied only to Elbit’s own product mix. You are still relying on the broader Israeli equity market to carry that diversification for you.
Not every stock inside EIS is priced the same way. Find out how many of EIS’s holdings look undervalued.
VanEck Israel ETF (ISRA)
Palo Alto Networks and Teva Pharmaceutical Industries shape much of what you own through ISRA, together making up 21.8% of the ETF. The portfolio allocation across systems software, diversified banks and pharmaceuticals closely resembles EIS, with Elbit Systems a smaller slice at 4.13%. Each US$1,000 in ISRA holds about US$41 of Elbit Systems, so most of your result comes from these other sectors rather than from the defense contractor alone.
Defense spending that stays in low single digit growth or shifts away from Elbit Systems avionics and precision guided munitions would directly affect that business. ISRA has 4.1% of its money in aerospace and defense, while systems software, banks and healthcare rely on different demand drivers. As a result, this fund provides a broader industry spread around your Elbit exposure.
See how ISRA’s returns compare with the market, from one week to five years
Amplify BlueStar Israel Technology ETF (ITEQ)
Each US$1,000 in ITEQ holds about US$72 of Elbit Systems, so you carry a real slice of the company’s risk inside this fund. The stock is the second largest position at 7.25%, alongside a bigger stake in Palo Alto Networks and a meaningful weight in JFrog. Around those, most of your exposure tilts toward software and digital infrastructure, with systems software at 30.1%, application software at 8.4% and IT consulting and related services at 5.8%. About 47% of ITEQ overlaps ISRA, and the stronger pull toward software and smaller positions in renewable electricity and semiconductors gives it a different flavour.
Aerospace and Elbit Systems of America already showed low single digit revenue declines in the quarter, and if US defense budgets grow only slowly or move away from avionics and precision guided munitions, that pressure would fall directly on Elbit Systems. ITEQ has 8.6% in aerospace and defense, so that specific worry stretches beyond one stock. Its larger exposure to software and renewable electricity ties much of your outcome to different end markets but still leaves defense spending decisions as an important swing factor for this ETF.
See what you’d actually own if you bought ITEQ, from its 61 positions to how much sits in the top 10.
Choosing your Elbit Systems fund exposure
You are really choosing how much of your Elbit Systems view you want inside banks and healthcare, or inside technology and defense. EIS and ISRA look closest, with Elbit at about US$52 and US$41 per US$1,000 and very similar holdings at the top. Each charges US$59 a year on US$10,000, and EIS simply spreads that across more stocks with 129 positions compared with 83 in ISRA.
ITEQ focuses more on software and defense, with about US$72 of Elbit per US$1,000 and 61 holdings, and costs US$75 a year on US$10,000. With that larger tilt, the recent strong quarter and record order backlog have more influence, as does the risk that defense priorities could move away from Elbit’s key product areas. Your decision is whether you want broader Israel, a tech-leaning mix, or a more concentrated exposure to Elbit alongside software.
Palo Alto Networks is the largest holding in both ISRA and ITEQ, so you’d own it either way. Check whether Palo Alto Networks trades above or below its fair value.
Fund data as of 13 November 2026. Portfolio holdings as of 12 November 2026.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
